Cargando…
The deubiquitinating enzyme STAMBP is a newly discovered driver of triple-negative breast cancer progression that maintains RAI14 protein stability
Triple-negative breast cancer (TNBC) is a heterogeneous malignancy in women. It is associated with poor prognosis, aggressive malignant behavior, and limited treatment options. In the ubiquitin‒proteasome system (UPS), deubiquitinases (DUBs) are potential therapeutic targets for various tumors. In t...
Autores principales: | Yang, Qianqian, Yan, Ding, Zou, Chaoying, Xue, Qian, Lin, Shuhui, Huang, Qingtian, Li, Xiaofen, Tang, Daolin, Chen, Xin, Liu, Jinbao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723177/ https://www.ncbi.nlm.nih.gov/pubmed/36434041 http://dx.doi.org/10.1038/s12276-022-00890-1 |
Ejemplares similares
-
Mutations in STAMBP, encoding a deubiquitinating enzyme, cause Microcephaly-Capillary Malformation syndrome
por: McDonell, Laura M., et al.
Publicado: (2013) -
Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity
por: Bednash, Joseph S., et al.
Publicado: (2017) -
STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway
por: Xu, Hui, et al.
Publicado: (2021) -
Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination
por: Liao, Yuning, et al.
Publicado: (2018) -
Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1
por: Guo, Yusong, et al.
Publicado: (2021)